Dyslipidemia in Patients with Chronic and End-Stage Kidney Disease

被引：21
|
作者：
Omran, Jad [1 ]
Al-Dadah, Ashraf [3 ]
Dellsperger, Kevin C. [2 ,3 ]
机构：
[1] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO 65212 USA
[2] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA
[3] Univ Missouri, Sch Med, Div Cardiovasc Med, Columbia, MO 65212 USA
来源：
CARDIORENAL MEDICINE | 2013年 / 3卷 / 03期
关键词：
Dyslipidemia; Oxidized low-density lipoprotein; Chronic kidney disease; End-stage renal disease; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; EXPANDED CLINICAL-EVALUATION; RENAL-TRANSPLANT RECIPIENTS; TYPE-2; DIABETES-MELLITUS; EXTENDED-RELEASE NIACIN; ESTER TRANSFER PROTEIN; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; PRIMARY-PREVENTION;
D O I：
10.1159/000351985
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the pathophysiological mechanisms and treatment of dyslipidemia in this special patient population. Copyright (C) 2013 S. Karger AG, Basel
引用
收藏
页码：165 / 177
页数：13
相关论文
共 50 条
  • [31] Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease
    Kalender, B
    Ozdemir, AC
    Koroglu, G
    NEPHRON CLINICAL PRACTICE, 2006, 102 (3-4): : C115 - C121
  • [32] Association between depression and inflammatory/anti-inflammatory cytokines in chronic kidney disease and end-stage renal disease patients: A review of literature
    Taraz, Mohammad
    Taraz, Saeideh
    Dashti-Khavidaki, Simin
    HEMODIALYSIS INTERNATIONAL, 2015, 19 (01) : 11 - 22
  • [33] Role of Dyslipidemia in Patients With Chronic Kidney Disease
    Marino, Anna
    Tannock, Lisa R.
    POSTGRADUATE MEDICINE, 2013, 125 (04) : 28 - 37
  • [34] Preventive health care in chronic kidney disease and end-stage renal disease
    Choudhury, Devasmita
    Luna-Salazar, Cynthia
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (04): : 194 - 206
  • [35] Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease
    Tsai, Yi-Chun
    Hung, Chi-Chih
    Hwang, Shang-Jyh
    Wang, Shu-Li
    Hsiao, Shih-Ming
    Lin, Ming-Yen
    Kung, Lan-Fang
    Hsiao, Pei-Ni
    Chen, Hung-Chun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (05) : 1621 - 1626
  • [36] Chronic and End-Stage Kidney Disease in the Neurological Intensive Care Unit
    Stern-Nezer, Sara
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (09)
  • [37] Nutrition education in the care of patients with chronic kidney disease and end-stage renal disease
    Anderson, Cheryl A. M.
    Hoang Anh Nguyen
    SEMINARS IN DIALYSIS, 2018, 31 (02) : 115 - 121
  • [38] Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review
    Pryor, Joseph B.
    Weber, Bo R.
    Weber, Jacob, V
    Lockridge, Joseph B.
    Olyaei, Ali J.
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (09) : 431 - 441
  • [39] The Risk of Stroke in Kidney Transplant Recipients with End-Stage Kidney Disease
    Huang, Shih-Ting
    Yu, Tung-Min
    Chuang, Ya-Wen
    Chung, Mu-Chi
    Wang, Chen-Yu
    Fu, Pin-Kuei
    Ke, Tai-Yuan
    Li, Chi-Yuan
    Lin, Cheng-Li
    Wu, Ming-Ju
    Kao, Chia-Hung
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (03)
  • [40] Metabolic Derangements Seen in Chronic Kidney Disease and End-Stage Renal Disease Patients
    Gupta, Diptesh
    Misra, Madhukar
    HEMODIALYSIS: NEW METHODS AND FUTURE TECHNOLOGY, 2011, 171 : 113 - 119
12345